Vaxcyte, Inc. - PCVX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$11.03B

QoQ value delta ($000)

+$1.43B (+14.9%)

Implied price effect (QoQ)

+0.09%

Total shares

189,796,766

QoQ shares delta

+24,460,980 (+14.79%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 338 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
FMR LLC	1,212,179	20,852,907	0.05%
Jupiter Topco LLC	1,044,355	17,965,847	0.43%
JANUS HENDERSON GROUP PLC	960,231	16,575,875	0.46%
T. Rowe Price Investment Management, Inc.	709,620	12,207,450	0.47%
BlackRock, Inc.	701,520	12,068,129	0.01%
RA CAPITAL MANAGEMENT, L.P.	667,018	11,474,599	5.8%
WELLINGTON MANAGEMENT GROUP LLP	407,000	7,001,565	0.07%
VANGUARD PORTFOLIO MANAGEMENT LLC	383,283	6,593,551	0.02%
VANGUARD CAPITAL MANAGEMENT LLC	369,048	6,348,679	0.01%
STATE STREET CORP	311,090	5,351,698	0.01%
Deep Track Capital, LP	249,959	4,300,000	3.64%
GEODE CAPITAL MANAGEMENT, LLC	201,130	3,459,363	0.01%
PRICE T ROWE ASSOCIATES INC /MD/	173,751	2,988,999	0.02%
Kynam Capital Management, LP	169,875	2,922,335	9.39%
WESTFIELD CAPITAL MANAGEMENT CO LP	143,722	2,472,428	0.47%
Caligan Partners LP	127,225	2,188,636	5.99%
Paradigm Biocapital Advisors LP	123,692	2,127,852	2.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	120,823	2,078,506	0.01%
Bellevue Group AG	114,628	1,971,935	2.41%
D. E. Shaw & Co., Inc.	110,555	1,901,872	0.05%
Caption Management, LLC	98,640	1,696,900	0.46%
MAVERICK CAPITAL LTD	93,777	1,613,242	0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	85,149	1,464,812	0.01%
Pivotal bioVenture Partners Investment Advisor LLC	82,862	1,425,470	26.92%
EVENTIDE ASSET MANAGEMENT, LLC	80,229	1,380,219	1.07%